Rabany Clayborn
Psychiatric/Mental Health · Milwaukee, WINPI 1003163460
Payments from drug & device makers
Across 94 payments — averaging $23.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$727
- Otsuka America Pharmaceutical, Inc.$383
- Lundbeck LLC$235
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$226
- Alkermes, Inc.$101
- Vanda Pharmaceuticals Inc.$97
- plus $451 from 12 others
What the payments were for
- Food & beverage$2,220100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $727 |
| Otsuka America Pharmaceutical, Inc. | 12 | $383 |
| Lundbeck LLC | 13 | $235 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $226 |
| Alkermes, Inc. | 4 | $101 |
| Vanda Pharmaceuticals Inc. | 5 | $97 |
| E.r. Squibb & Sons, L.L.C. | 3 | $76 |
| Johnson & Johnson | 3 | $75 |
| Aimmune Therapeutics, Inc. | 3 | $62 |
| Astellas Pharma US Inc | 2 | $55 |
| AstraZeneca | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Sage Therapeutics, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Viiv Healthcare Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$250
- NUEDEXTA$125
- ABILIFY MAINTENA$122
- ABILIFY ASIMTUFII$122
- CAPLYTA$105
How this compares
$2,220 in reported general payments places this provider in the 80th percentile of 384 psychiatric/mental health providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 32 | $49,771 |
| Invega SustennaPaliperidone Palmitate | 12 | $41,238 |
| Lurasidone Hcl | 48 | $13,908 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,374 |
| Ramelteon | 37 | $5,613 |
| Aripiprazole | 57 | $1,949 |
| Mirtazapine | 110 | $1,411 |
| Hydroxyzine Hcl | 54 | $1,368 |
| Buspirone Hcl | 135 | $1,295 |
| Bupropion XlBupropion Hcl | 78 | $1,294 |
| Haloperidol | 39 | $1,018 |
| Duloxetine Hcl | 70 | $1,009 |
| Ziprasidone Hcl | 17 | $874 |
| Naltrexone Hcl | 20 | $800 |
| Olanzapine | 46 | $752 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $727 | $49,77132 claims |
| Johnson & JohnsonInvega Sustenna | $75 | $41,23812 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $19 | $6,37413 claims |
| Lilly USA, LLCOlanzapine | $15 | $75246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 384 psychiatric/mental health providers in Wisconsin.
Other psychiatric/mental health in Milwaukee
- Carolyn DavidsonMilwaukee$46K
- Sherry AleksichMilwaukee$33K
- Ngozi ObioraMilwaukee$19K
- Victoria McGinleyMilwaukee$9K
- Andrea MitchellMilwaukee$6K
- Angeline VercauterenMilwaukee$6K
- Lisa CwiklaMilwaukee$5K
- Julia JasterMilwaukee$5K
- Angelia Felton-WilksMilwaukee$4K
- Kristen AndersonMilwaukee$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.